1. Padeken, Jan, Methot, Stephen P, Gasser, Susan M. 2022. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. In Nature reviews. Molecular cell biology, 23, 623-640. doi:10.1038/s41580-022-00483-w. https://pubmed.ncbi.nlm.nih.gov/35562425/
2. Li, Baihui, Zheng, Yu, Yang, Lili. 2019. The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View. In Journal of Cancer, 10, 721-729. doi:10.7150/jca.28254. https://pubmed.ncbi.nlm.nih.gov/30719171/
3. Wang, Lei, Chakraborty, Damayanti, Iqbal, Khursheed, Soares, Michael J. 2021. SUV39H2 controls trophoblast stem cell fate. In Biochimica et biophysica acta. General subjects, 1865, 129867. doi:10.1016/j.bbagen.2021.129867. https://pubmed.ncbi.nlm.nih.gov/33556426/
4. Wang, Kan, Zhu, Qiang Zhang, Ma, Xian Tao, Cheng, Cai. 2021. SUV39H2/KMT1B Inhibits the cardiomyocyte senescence phenotype by down-regulating BTG2/PC3. In Aging, 13, 22444-22458. doi:10.18632/aging.203551. https://pubmed.ncbi.nlm.nih.gov/34559682/
5. Bauer, A, Nimmo, J, Newman, R, Jagannathan, V, Leeb, T. 2018. A splice site variant in the SUV39H2 gene in Greyhounds with nasal parakeratosis. In Animal genetics, 49, 137-140. doi:10.1111/age.12643. https://pubmed.ncbi.nlm.nih.gov/29423952/
6. Zheng, Yu, Li, Baihui, Wang, Jian, Wu, Lei, Yang, Lili. 2018. Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma. In Clinical epigenetics, 10, 129. doi:10.1186/s13148-018-0562-4. https://pubmed.ncbi.nlm.nih.gov/30348215/
智鼠故事 
